CI Investments Inc’s Ultragenyx Pharmaceutical RARE Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2025
Q2 | – | Sell |
-1,330
| Closed | -$48K | – | 1317 |
|
|
2025
Q1 | $48K | Sell |
1,330
-6
| -0.4% | -$217 | ﹤0.01% | 1030 |
|
|
2024
Q4 | $56K | Sell |
1,336
-241
| -15% | -$10.1K | ﹤0.01% | 1017 |
|
|
2024
Q3 | $88K | Buy |
1,577
+12
| +0.8% | +$670 | ﹤0.01% | 874 |
|
|
2024
Q2 | $64K | Buy |
1,565
+309
| +25% | +$12.6K | ﹤0.01% | 918 |
|
|
2024
Q1 | $59K | Buy |
1,256
+1
| +0.1% | +$47 | ﹤0.01% | 988 |
|
|
2023
Q4 | $60K | Buy |
+1,255
| New | +$60K | ﹤0.01% | 930 |
|
|
2022
Q4 | – | Sell |
-128
| Closed | -$5K | – | 1327 |
|
|
2022
Q3 | $5K | Sell |
128
-9
| -7% | -$352 | ﹤0.01% | 1151 |
|
|
2022
Q2 | $8K | Sell |
137
-29
| -17% | -$1.69K | ﹤0.01% | 1050 |
|
|
2022
Q1 | $12K | Buy |
166
+163
| +5,433% | +$11.8K | ﹤0.01% | 1075 |
|
|
2021
Q4 | $0 | Hold |
3
| – | – | ﹤0.01% | 1412 |
|
|
2021
Q3 | $0 | Buy |
+3
| New | – | ﹤0.01% | 1362 |
|
|
2021
Q1 | – | Sell |
-4,527
| Closed | -$627K | – | 1046 |
|
|
2020
Q4 | $627K | Buy |
+4,527
| New | +$627K | ﹤0.01% | 445 |
|